Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Antibiotic Tissue Penetration in Head and Neck Infection and Reconstructive Surgery

Official title: Antibiotic Penetration and Tissue Response in Infection and Reconstructive Surgery of the Head and Neck Region: A Microdialysis Study of Cefuroxime, Cloxacillin, Dicloxacillin, and Amoxicillin/Clavulanic Acid

Run by Aarhus University Hospital · NCT07896239 · Data updated 2026-11-12

This study tests how well common antibiotics reach head and neck tissue in adults with neck infections or during nasal reconstructive surgery using a flap.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment16 (estimated)
SponsorAarhus University Hospital
Academic / other
Locations1 site (Aarhus N)
StatusRecruiting
StartedNovember 2026
Main results expectedSeptember 2028
Study endsDecember 2028
Registry record updatedNovember 4, 2026
Trial IDNCT07896239 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with either a postoperative neck infection or planned inferior turbinate flap nasal reconstruction who consent to participate and have no study drug allergies or severe kidney impairment.

Probably not a fit

Patients with infections or surgical scenarios outside the defined sub-studies or those unable to complete microdialysis sampling may not benefit from the findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, non-randomized, open-label interventional study with two sub-studies enrolling 16 adults. It uses microdialysis and serial blood sampling to measure tissue and plasma antibiotic concentrations over a defined dosing period. Sub-study 1 focuses on postoperative neck infection and compares two cefuroxime-based regimens with additional penicillin-type antibiotics. Sub-study 2 evaluates antibiotic penetration in patients undergoing reconstruction with an inferior turbinate flap. The study aims to determine how long drug concentrations stay above the MIC in infected tissue, non-infected tissue, the flap, and plasma, and to describe markers of ischemia and inflammation in the flap during early postoperative days.

Why it matters

Potential benefit: If successful, results could inform dosing strategies to ensure effective tissue drug levels in head and neck infections and during flap reconstruction.

How similar studies have gone: Previous work demonstrates that microdialysis can characterize tissue drug penetration, but this study explores this in the context of head and neck infection and reconstructive flap tissue, which is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Signed informed consent
* Either a postoperative infection in the neck (sub-study 1) or planned reconstruction with an inferior turbinate flap (sub-study 2)
* Age 18 years or older

Exclusion Criteria:

* Known allergy or hypersensitivity to any of the study antibiotics (cefuroxime, cloxacillin, dicloxacillin, or amoxicillin/clavulanic acid)
* eGFR below 30 mL/min/1.73 m2
* Pregnancy or planned pregnancy

Where it's running

  • Aarhus University Hospital, Department of Otorhinolaryngology, Head and Neck Surgery
    Aarhus N, Denmark
    Recruiting

Study contacts

  • Principal investigator: Tejs Ehlers Klug, MD, DMSc — Aarhus University Hospital
  • Study coordinator: Pelle Hanberg, MD, PhD
  • Email: pellehanberg@clin.au.dk
  • Phone: +45 28744852

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.